Home Registration Schedule Directions Contact

Schedule



Note on Playing Webcasts (FAQ)
Webcasts may be played in either Firefox or Chrome web browsers (File --> Open File) or within the VLC media player.
Additional information on playing .ogv files may be found here.


8:30-9:00am
Miller Room
Havemeyer 328
Breakfast

9:00am-10:30am
Havemeyer 209
Morning Session I
9:00-9:45am
Ron Levy
Department of Chemistry & Chemical Biology, Rutgers University
"Binding energy distribution analysis method (BEDAM) for estimating protein-ligand affinities with implicit solvation"
Presentation: Abstract | Slides (.ppt)
Webcast: High Res | Low Res | FAQ
9:45-10:30am
Woody Sherman
Vice President, Applications Science, Schrodinger, Inc.
"Recent Advances in Structure-Based Drug Design"
Presentation: Abstract | Slides (.pdf)
Webcast: High Res | Low Res | FAQ

10:30-10:45am
Miller Room
Havemeyer 328
Coffee Break

10:45am-12:15pm
Havemeyer 209
Morning Session II
10:45-11:30am
Natasja Brooijmans
Novartis
"Structure-based Drug Discovery in a Data-Driven Era"
Presentation: Abstract | Slides (.pdf)
11:30am-12:15pm
Rich Friesner
Department of Chemistry, Columbia University
"Physics-based scoring of protein ligand complexes incorporating hydrophobic enclosure and water thermodynamics"
Presentation: Abstract | Slides (.ppt)
Webcast: High Res | Low Res | FAQ

12:15-1:30pm
7th Floor Lounge
Havemeyer Hall
Lunch

1:30-3:00pm
Havemeyer 209
Afternoon Session I
1:30-2:15pm
Ron Dror
DESRES
"Long-Timescale Molecular Dynamics Simulation as a Tool for Understanding Drug Targets"
Presentation: Abstract
2:15-3:00pm
Curt Breneman
Rensselaer Polytechnic Institute
"Predictive cheminformatics strategies for anticipating good and bad side effects: New methods for predicting multiple-CYP metabolic sites and off-target polypharmacology"
Presentation: Abstract | Slides (.pdf)
Webcast: High Res | Low Res | FAQ

3:00-3:15pm
Miller Room
Havemeyer 328
Coffee Break

3:15-5:00pm
Havemeyer 209
Afternoon Session II
3:15-4:00pm
Stefano Costanzi
NIH
"G protein-coupled receptors: docking-based virtual screening and mechanistic insights into agonist binding"
Presentation: Abstract
4:00-5:00pm
Devleena Shivakumar
Schrodinger, Inc.
Ligand- and Structure- Based Drug Design Demo
Webcast: High Res | Low Res | FAQ

5:00-6:00pm
7th Floor Lounge
Havemeyer Hall
Reception and Poster Session
Please join us for a wine and hors d'oeuvres reception and poster session. The following posters will be presented:
Analysis of Protein-DNA Interactions Through Changes in Buried Surface Area
Edward Miller, Remo Rohs, Sean West, and Barry Honig
Integrated Program in Cellular, Molecular, and Biomedical Studies; Columbia University
Does the intrinsically disordered p53 C-terminal peptide bind its multiple partners using conformational selection?
Virginia M. Burger and Lillian T. Chong
Department of Computational Biology, University of Pittsburgh
An in silico stereo-electronic comparison of conventional pyridinium oximes and K-oximes for organophosphate (OP) poisoning
Apurba K. Bhattacharjee and Richard K. Gordon
Department of Regulated Laboratories, Division of Regulated Activities, Walter Reed Army Institute of Research (WRAIR)
In Pursuit of Virtual Lead Optimization: The Treatment and Application of Ensembles for Improved Ligand Ranking
Janet L. Paulsen, Jeffrey A. Endicott, and Amy C. Anderson
Department of Pharmaceutical Sciences, University of Connecticut
Sticking together or keeping apart: targeting multimerization for in silico small molecule inhibitory discovery
Ursula D. Ramirez, Linda Stith, Lenka Kundrat, Faina Myachina, and Eileen K. Jaffe
Fox Chase Cancer Center
Structure-based inhibitor discovery for the RING-domain E3-ligase c-Cbl
Andras J. Bauer, Reka R. Letso, and Brent R. Stockwell
Howard Hughes Medical Institute, Department of Biological Sciences, Columbia University; and Department of Chemistry, Columbia University
Library-based Monte Carlo as a convenient platform for variable-resolution protein models
Artem B. Mamonov and Daniel M. Zuckerman
Department of Computational Biology, University of Pittsburgh Medical School
Why is α4β2 nAChR More Sensitive to Volatile Anesthetics than α7 nAChR?
D. Mowrey, L. Liu, D. Willenbring, E. Haddadian, Y. Xu, and P. Tang
Department of Anesthesiology, University of Pittsburgh School of Medicine; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine; Department of Structural Biology, University of Pittsburgh School of Medicine
A Protein Trajectory Reconstruction Strategy from FRET-derived Distance Constraints
Andrej Savol and Chakra Chennubhotla
Deptartment of Computational Biology, School of Medicine, University of Pittsburgh
Peptide and peptidomimetic inhibitors of Botulinum neurotoxin serotype A - SAR and pharmacophore modeling
Gyanendra Kumar, Desigan Kumaran, S. Ashraf Ahmad, Subramanyam Swaminathan
Biology Department, Brookhaven National Laboratory; Department of Molecular Biology, Integrated Toxicology Division, U.S. Army Medical Research Institute of Infectious Diseases



site design by Jeffrey Lancaster || last updated 07.08.10